NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures

NCT ID: NCT00969839

Last Updated: 2009-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational, prospective, nonrandomized open label, post-market clinical study, designed to evaluate the use a flexible intramedullary fixation device used in the treatment of fractures of the humerus. This is a multicentre trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intramedullary Fixation System

Humeral fractures to be treated with the Intramedullary Fixation System

Group Type EXPERIMENTAL

NovaLign Intramedullary Fixation System

Intervention Type DEVICE

Intramedullary fixation of broken humerus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NovaLign Intramedullary Fixation System

Intramedullary fixation of broken humerus

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Humeral Fracture
* Surgical intervention can be performed within 14 days of injury (injury being Day 0 for this particular criteria)
* Fully functioning contralateral limb (e.g., hand, arm, shoulder)
* Age 18 years or older and skeletally mature

Exclusion Criteria

* Intraarticular fractures or those involving shoulder or elbow of the index arm
* Pathologic fracture (e.g., tumor involvement, osteomalacia, etc.; osteoporosis is not an exclusion)
* Evidence of neurologic injury in the index arm, including compartment syndrome or radial nerve palsy
* Additional upper body injuries (e.g., upper extremity, abdominal, thoracic, neck or head injury) that may affect or inhibit the evaluation of the index or contralateral arm, shoulder, elbow, etc or would not allow the patient to follow or comply with appropriate post-operative regimens
* Any previous bodily injury or surgery that may interfere with function or evaluation of index or contralateral arm, shoulder, elbow, etc.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NovaLign Orthopaedics, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NovaLign Orthopaedics

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

B Crist, MD

Role: PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Denver Health Medical Center

Denver, Colorado, United States

Site Status RECRUITING

University of Missouri - Columbia

Columbia, Missouri, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

S Morgan, MD

Role: primary

303-602-3796

A Baron

Role: backup

(303) 602-3796

B Crist, MD

Role: primary

573-884-0854

L Anderson, RN

Role: backup

(573) 884-0854

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SP-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ZNN Bactiguard Cephalomedullary Nails PMCF Study
NCT05362864 ACTIVE_NOT_RECRUITING
Perform® Humeral System - Fracture Study (PFX)
NCT05773352 ACTIVE_NOT_RECRUITING